Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionSchroder Investment Management Group
Latest Disclosed Ownership71,711 shares
Latest Disclosed Value $ 9,447,207
Schroder Investment Management Group reports 17.60% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Schroder Investment Management Group filed a 13F-HR form disclosing ownership of 71,711 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $9,447,207 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 87,026 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -17.60% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 71,711 -15,315 -17.60 9,447 -23.46 0.0015
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 87,026 84,225 3,006.96 12,343 3,048.47 0.0094
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,801 -26,131 -90.32 393 -89.22 0.0003
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,932 -803 -2.70 3,636 10.58 0.0031
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 29,735 -97,000 -76.54 3,289 -80.99 0.0033
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 126,735 -84,539 -40.01 17,299 -28.93 0.0166
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 211,274 25,890 13.97 24,343 -4.62 0.0249
2024-08-12 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 185,384 35,257 23.48 25,522 23.26 0.0281
2024-05-14 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 150,127 74,592 98.75 20,706 108.05 0.0244
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 75,535 17,931 31.13 9,952 53.58 0.0129
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,604 -5,689 -8.99 6,480 8.58 0.0096
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 63,293 7,451 13.34 5,969 5.59 0.0086
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 55,842 48,729 685.07 5,652 565.72 0.0084
2023-02-10 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,113 -3,319 -31.82 850 -23.38 0.0013
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,432 10,432 1,108 0.0018
2020-02-11 2019-12-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 0 -3,180 -100.00 0 -100.00
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 3,180 278 9.58 287 17.14 0.0005
2019-11-14 2019-06-30 13F/A-2 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 2,902 -11,274 -79.53 245 -80.38 0.0004
2019-08-15 2019-06-30 13F/A-1 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 2,902 -11,274 245 262.8197
2019-08-08 2019-06-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 2,902 -11,274 245 262.8486
2019-11-15 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 14,176 5,440 62.27 1,249 100.16 0.0022
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 14,176 5,440 1,249 2,028.6331
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 8,736 -10,214 -53.90 624 -73.22 0.0011
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 18,950 -5,549 -22.65 2,330 -2.18 0.0040
2018-08-23 2018-06-30 13F/A-2 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 24,499 0 0.00 2,382 17.22 0.0042
2018-08-16 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 24,499 0 2,382 4,170.2752
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 24,499 0 2,382 4,217.8550
2018-05-11 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 24,499 -4,477 -15.45 2,032 -9.61 0.0035
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 24,499 -4,477 2,032 3,521.2902
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 28,976 -8,129 -21.91 2,248 2.00 0.0037
2017-11-09 2017-09-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 37,105 16,609 81.04 2,204 132.49 0.0038
2017-08-10 2017-06-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 20,496 0 0.00 948 10.75 0.0017
2017-05-18 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 20,496 335 1.66 856 9.74 0.0015
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 20,496 335 856 1,538.6548
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 20,161 -7,046 -25.90 780 -43.40 0.0015
2016-11-09 2016-09-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 27,207 -18,082 -39.93 1,378 -33.04 0.0026
2016-08-08 2016-06-30 13F NEUROCRINE BIOSCIENCES INCORPORATED USD0.001 COM 64125C109 45,289 45,289 1.76 2,058 -99.59 0.0041
2014-02-14 2013-12-31 13F NeurocrineBiosc.ComStkUSD0.001 COM 64125C109 0 -44,507 -100.00 0 -100.00
2013-12-09 2013-09-30 13F/A-1 NeurocrineBiosc.ComStkUSD0.001 COM 64125C109 503,819 459,312 5,703 171.8324
2013-12-10 2013-09-30 13F/A-2 NeurocrineBiosc.ComStkUSD0.001 COM 64125C109 44,507 44,507 504 0.0012
2013-11-08 2013-09-30 13F NeurocrineBiosc.ComStkUSD0.001 COM 64125C109 44,507 504
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.